What is Alarelin?
Alarelin is a releasing hormone, also known as gonadotrophin. It is a synthetic LH-RH agonist that is found in higher amounts than that of LH-RH in vivo and in vitro and in ovulation inductions. It is a kind of drug, popularly used to treat endometriosis or hysteromyoma.
Alarelin is majorly used for medical research to study the drug's effects on an animal's body, for conditions associated with the reproductive study. It is best to prefer alarelin with a doctor's prescription, improves testosterone levels in men, treats endometriosis in females, stimulates your pituitary gland to produce more LH and FSH, help in reducing aging symptoms and solves reproduction challenges in women.
Global Alarelin Market Outlook
Growing prevalence of endometriosis and increasing research in healthcare is driving the growth of alarelin market. Endometriosis is found in females, with proven fertility undergoing tubal sterilization procedures. The accurate incidence of endometriosis in the general population is unidentified. Prevalence estimates are based on a surgical population in which the likelihood of disease is greater. According to "An international Journal of Obstetrics and gynaecology", the point prevalence of endometriosis was 10.8 per 1000. Females aged 40-44 years had the highest prevalence rate of 18.6 per 1000. The condition has a prevalence rate of 20-50% in infertile women, but it can be as greater as 71-87% in women with chronic pelvic pain. Apart from all these, alarelin usage does have some harmful side effects or can lead to other health complications which may restrain the growth of the market. Some of the alarelin side effects include dry mouth, joint pains, increased water retention caused by overdosing the drug, pains or itchiness around the injection areas, increased hunger and can lead to weight loss/gain.
Global Alarelin Market Competitive Analysis
The "Global Alarelin Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such Santa Cruz Biotechnology, JSN Chemicals, BBCA Group, Shanghai Soho-Yiming Pharmaceuticals, Hangzhou Longshine Bio-Tech, ALB Technology Limited, LGM Pharma., Chemwill Asia Co.,Ltd., Rixing Chemical CO.,LTD, and Henan Tianfu Chemical Co.,Ltd. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL ALARELIN MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL ALARELIN MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL ALARELIN MARKET, BY TYPE
5.1. Overview
5.2. Alarelin 98%
5.3. Alarelin 99%
5.4. Other
6. GLOBAL ALARELIN MARKET, BY FORM
6.1. Overview
6.2. Powder
6.3. Solution
7. GLOBAL ALARELIN MARKET, BY APPLICATION
7.1. Overview
7.2. Uterine Fibroids
7.3. Endometriosis
7.4. Other
8. GLOBAL ALARELIN MARKET, BY GEOGRAPHY
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Rest of Europe
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia Pacific
8.5. Rest of the World
9. GLOBAL ALARELIN MARKET COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Company Market Ranking
9.3. Key Development Strategies
10. COMPANY PROFILES
10.1. Santa Cruz Biotechnology
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2. JSN Chemicals
10.2.1. Overview
10.2.2. Financial Performance
10.2.3. Product Outlook
10.2.4. Key Developments
10.3. BBCA Group
10.3.1. Overview
10.3.2. Financial Performance
10.3.3. Product Outlook
10.3.4. Key Developments
10.4. Shanghai Soho-Yiming Pharmaceuticals
10.4.1. Overview
10.4.2. Financial Performance
10.4.3. Product Outlook
10.4.4. Key Developments
10.5. Hangzhou Longshine Bio-Tech
10.5.1. Overview
10.5.2. Financial Performance
10.5.3. Product Outlook
10.5.4. Key Developments
10.6. ALB Technology Limited
10.6.1. Overview
10.6.2. Financial Performance
10.6.3. Product Outlook
10.6.4. Key Developments
10.7. LGM Pharma.
10.7.1. Overview
10.7.2. Financial Performance
10.7.3. Product Outlook
10.7.4. Key Developments
10.8. Chemwill Asia Co. Ltd.
10.8.1. Overview
10.8.2. Financial Performance
10.8.3. Product Outlook
10.8.4. Key Developments
10.9. Rixing Chemical CO. LTD.
10.9.1. Overview
10.9.2. Financial Performance
10.9.3. Product Outlook
10.9.4. Key Developments
10.10. Henan Tianfu Chemical Co, Ltd.
10.10.1. Overview
10.10.2. Financial Performance
10.10.3. Product Outlook
10.10.4. Key Developments
11. Appendix
11.1. Related Reports
| Price : US$ 3500 | Date : Sep 2023 |
| Category : Healthcare and Pharmaceuticals | Pages : 162 |
| Price : US$ 3500 | Date : Jul 2023 |
| Category : Healthcare and Pharmaceuticals | Pages : 145 |
| Price : US$ 3500 | Date : Sep 2022 |
| Category : Healthcare and Pharmaceuticals | Pages : 157 |
| Price : US$ 3000 | Date : Apr 2022 |
| Category : Healthcare and Pharmaceuticals | Pages : 114 |
| Price : US$ 3000 | Date : Apr 2022 |
| Category : Healthcare and Pharmaceuticals | Pages : 105 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
